AstraZeneca
Fusion Pharmaceuticals, a clinical-stage oncology company within the AstraZeneca Group, develops next-generation radioconjugates for targeted cancer therapy. The Director, CMC Project Leadership is a senior role based in Boston (hybrid) supporting the company’s clinical development portfolio and representing CMC on the Global Program Team for the lead asset FPI-2265.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
CMC Portfolio Lead
American Association of Physicists in Medicine
Executive Director, Global CMC Lead
Revolution Medicines
Scientist - Radiochemistry
American Association of Physicists in Medicine
CMC Lead
BeOne Medicines
Associate Director, CMC Product Development – Small Molecule
Beeline Medicines
Manager, CMC Project Management
Crescent Biopharma